Trials / Completed
CompletedNCT03217721
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit : New Recommendations do They Change Our Clinical Practice ?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Neutropenia, defined by an absolute count of polymorphonuclear neutrophils less than \<1500/mm3, exposes patients to infectious complications that can lead to sepsis or septic shock. The mortality risk is higher risk. The recommendations published in 2016 were formulated to homogenize the clinical practices to improve the survival.
Detailed description
We evaluate the adequacy antibiotics prescriptions in febrile neutropenia with suspected infection and evaluate factors influencing adequacy therapy and mortality consequence.
Conditions
Timeline
- Start date
- 2017-06-19
- Primary completion
- 2017-09-19
- Completion
- 2017-09-19
- First posted
- 2017-07-14
- Last updated
- 2024-08-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03217721. Inclusion in this directory is not an endorsement.